1. Molineux G, Newland A. Development of romiplostim for the treatment of patients with chronic immune thrombocytopenia: from bench to bedside. Br J Haematol. 2010;150(1):9–20.
2. NplateTM (romiplostim). Full prescribing information, Amgen Inc., Thousand Oaks, CA, 2008.
3. Beijnen JH, Schellens JH. Drug interactions in oncology. Lancet Oncol. 2004;5(8):489–96.
4. Keller F, Giehl M, Frankewitsch T, Zellner D. Pharmacokinetics and drug dosage adjustment to renal impairment. Nephrol Dial Transplant. 1995;10(9):1516–20.
5. Mould DR, Sweeney KR. The pharmacokinetics and pharmacodynamics of monoclonal antibodies–mechanistic modeling applied to drug development. Curr Opin Drug Discov Dev. 2007;10(1):84–96.